NO934282D0 - Calcium, trace metal, vitamin D and drug therapy combinations - Google Patents

Calcium, trace metal, vitamin D and drug therapy combinations

Info

Publication number
NO934282D0
NO934282D0 NO934282A NO934282A NO934282D0 NO 934282 D0 NO934282 D0 NO 934282D0 NO 934282 A NO934282 A NO 934282A NO 934282 A NO934282 A NO 934282A NO 934282 D0 NO934282 D0 NO 934282D0
Authority
NO
Norway
Prior art keywords
vitamin
calcium
drug therapy
trace metal
therapy combinations
Prior art date
Application number
NO934282A
Other languages
Norwegian (no)
Other versions
NO934282L (en
Inventor
Mark Benson Andon
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO934282D0 publication Critical patent/NO934282D0/en
Publication of NO934282L publication Critical patent/NO934282L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A23L33/155—Vitamins A or D
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/23—Calcitonins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO934282A 1991-05-28 1993-11-26 Calcium, trace metal, vitamin D and drug therapy combinations NO934282L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70583291A 1991-05-28 1991-05-28
PCT/US1992/003995 WO1992021355A1 (en) 1991-05-28 1992-05-15 Calcium, trace mineral, vitamin d and drug therapy combinations

Publications (2)

Publication Number Publication Date
NO934282D0 true NO934282D0 (en) 1993-11-26
NO934282L NO934282L (en) 1994-01-28

Family

ID=24835140

Family Applications (1)

Application Number Title Priority Date Filing Date
NO934282A NO934282L (en) 1991-05-28 1993-11-26 Calcium, trace metal, vitamin D and drug therapy combinations

Country Status (13)

Country Link
EP (1) EP0586521A1 (en)
JP (1) JPH07502012A (en)
KR (1) KR100244603B1 (en)
AU (1) AU666654B2 (en)
BR (1) BR9206072A (en)
CA (1) CA2109958C (en)
CZ (1) CZ281823B6 (en)
HU (1) HUT66379A (en)
IE (1) IE921701A1 (en)
NO (1) NO934282L (en)
NZ (1) NZ242920A (en)
SK (1) SK132693A3 (en)
WO (1) WO1992021355A1 (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674844A (en) * 1991-03-11 1997-10-07 Creative Biomolecules, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
US7056882B2 (en) 1991-03-11 2006-06-06 Curis, Inc. Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases
EP0600834A1 (en) * 1992-11-30 1994-06-08 Ciba-Geigy Ag Use of methanebisphosphonic acid derivatives for the manufacture of a medicament for fracture healing
AU670337B2 (en) 1992-11-30 1996-07-11 Novartis Ag Use of certain methanebisphosphonic acid derivatives in fracture healing
FR2704393B1 (en) * 1993-04-30 1995-06-02 Boiron Absorbable nutritional supplement to optimize growth and maintain strong bones.
US5763429A (en) * 1993-09-10 1998-06-09 Bone Care International, Inc. Method of treating prostatic diseases using active vitamin D analogues
FR2723682B1 (en) * 1994-08-19 1996-09-27 Boiron ABSORBABLE NUTRITIONAL SUPPLEMENT FOR THE DAILY BALANCE OF CHILDREN AND ADOLESCENTS.
IL115241A (en) * 1994-09-26 2000-08-31 American Cyanamid Co Calcium dietary supplement
DE19503190A1 (en) * 1995-02-01 1996-08-08 Dietl Hans Means for influencing disorders of bone formation
US5609897A (en) * 1995-04-07 1997-03-11 Abbott Laboratories Powdered beverage concentrate or additive fortified with calcium and vitamin D
US5597595A (en) * 1995-04-07 1997-01-28 Abbott Laboratories Low pH beverage fortified with calcium and vitamin D
US5698222A (en) * 1995-04-07 1997-12-16 Abbott Laboratories Calcium supplement
US5817351A (en) * 1995-04-07 1998-10-06 Abbott Laboratories Calcium fortified low pH beverage
CA2266098A1 (en) * 1996-09-26 1998-04-02 Oklahoma Medical Research Foundation Use of n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester and its derivatives in disease regression
US6503893B2 (en) 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
US6566353B2 (en) 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
US6573256B2 (en) 1996-12-30 2003-06-03 Bone Care International, Inc. Method of inhibiting angiogenesis using active vitamin D analogues
US6929797B2 (en) * 1997-02-13 2005-08-16 Bone Care International, Inc. Targeted therapeutic delivery of vitamin D compounds
GB9703109D0 (en) * 1997-02-14 1997-04-02 Smith & Nephew Compositions
US6479474B2 (en) 1999-07-08 2002-11-12 Wisconsin Alumni Research Foundation Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis
ES2394782T3 (en) * 2003-05-07 2013-02-05 Osteologix A/S Composition with strontium and vitamin D for the prophylaxis and / or treatment of cartilage and / or bone conditions
WO2005072539A1 (en) * 2004-01-28 2005-08-11 Dr. Paul Lohmann Gmbh Kg Method for the production of a calcium lactate malate compound and calcium lactate malate compound
EP1796683A1 (en) * 2004-07-15 2007-06-20 Nanobac Life Sciences Methods and compositions for the administration of calcium chelators, bisphosphonates and/or citrate compounds and their pharmaceutical uses
US7473684B2 (en) * 2005-09-16 2009-01-06 Selamine Limited Bisphosphonate formulation
WO2007098092A2 (en) * 2006-02-21 2007-08-30 Nutrijoy, Inc. Food and beverage products with improved taste impressions
JP5619334B2 (en) * 2006-06-14 2014-11-05 允聖 崔 Bone strengthening agent
US8889195B2 (en) * 2006-08-17 2014-11-18 The Procter & Gamble Company Compositions comprising calcium citrate malate and methods for making the same
CA2661062C (en) * 2006-08-17 2012-08-14 The Procter & Gamble Company Compositions comprising calcium citrate malate and methods for making the same
WO2009019307A2 (en) * 2007-08-09 2009-02-12 Novartis Ag Oral calcitonin compositions and applications thereof
HUE025737T2 (en) 2009-09-01 2016-05-30 Univ Duke Bisphosphonate compositions and methods for treating heart failure
CA2856030A1 (en) 2011-11-16 2013-05-23 Duke University Bisphosphonate compositions and methods for treating and/or reducing cardiac dysfunction

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992556A (en) * 1973-05-07 1976-11-16 Vitamins, Inc. Supplemented food product
GB8622025D0 (en) * 1986-09-12 1986-10-22 Beecham Group Plc Composition
FR2618305B1 (en) * 1987-07-23 1989-10-27 Synthelabo NUTRITIONAL MIXTURE FOR THE ELDERLY
JP2516794B2 (en) * 1988-02-26 1996-07-24 雪印乳業株式会社 Baby formula containing vitamin D metabolites
EP0343703A3 (en) * 1988-05-26 1990-06-06 The Procter & Gamble Company Mineral supplements with sugar alcohols
US5151274A (en) * 1990-08-06 1992-09-29 The Procter & Gamble Company Calcium and trace mineral supplements

Also Published As

Publication number Publication date
KR100244603B1 (en) 2000-03-02
NZ242920A (en) 1995-06-27
CZ281823B6 (en) 1997-02-12
JPH07502012A (en) 1995-03-02
CA2109958C (en) 1997-06-10
HUT66379A (en) 1994-11-28
IE921701A1 (en) 1992-12-02
SK132693A3 (en) 1994-06-08
WO1992021355A1 (en) 1992-12-10
AU666654B2 (en) 1996-02-22
CZ255393A3 (en) 1994-07-13
BR9206072A (en) 1994-11-15
NO934282L (en) 1994-01-28
HU9303364D0 (en) 1994-03-28
AU1996892A (en) 1993-01-08
EP0586521A1 (en) 1994-03-16

Similar Documents

Publication Publication Date Title
NO934282D0 (en) Calcium, trace metal, vitamin D and drug therapy combinations
IS3720A7 (en) Dialkoxy-pyridinyl-benzimidazole derivatives, their method and pharmaceutical use
DE68921798D1 (en) Therapeutic nuleosides.
FI903656A0 (en) THERAPEUTIC KINUCLIDIN INFOERING.
NO892380D0 (en) FUNCTIONAL AND BIO-COMPATIBLE BACKGROUNDS.
DK0616523T3 (en) drugs
NO910031D0 (en) IMMUNCONJUGATES FOR CANCER DIAGNOSTICS AND THERAPY.
FI913899A0 (en) THERAPEUTIC AEROSOLBLANDNINGAR.
FI893340A0 (en) FOERFARANDE FOER ATT ERHAOLLA PHARMACEUTICAL SAMMANSAETTNINGAR FOER ATT HINDRA SMITTBARA KOENSSJUKDOMAR.
DK623886A (en) ETHER-SUBSTITUTED ISONITRILS, RADIO-MARKED COMPLEXES THEREOF AND THEIR USE
NO308533B1 (en) Heteroarlamines, their use and pharmaceutical composition
NO923859D0 (en) DRUG
NO922275L (en) ARYLETERS, THEIR PREPARATION AND PROCEDURE FOR TREATMENT
NO943682D0 (en) Imidazol-4-yl-piperidine derivatives, their preparation and therapeutic use
MC2112A1 (en) EFFERVESCENT TABLET
DK91793D0 (en) PROCEDURE FOR SURFACE TREATMENT, MEDICINES FOR EXERCISE AND APPLICATION
FI904854A0 (en) THERAPEUTIC NUCLEOSIDER.
NO923536L (en) SUBSTITUTED AMINOPROPAN, PROCEDURE FOR MANUFACTURING AND USE
NO890522L (en) SUBSTITUTED IMIDAZOLINONES AND IMIDAZOLINTHIONES.
NO923455L (en) INDOLSULPHONAMIDE-SUBSTITUTED DIHYDROPYRIDINE, PROCEDURES FOR THE PRODUCTION AND USE OF PHARMACEUTICALS
ZA92357B (en) Amide derivatives and their therapeutic use.
FR2694702B3 (en) PERFECTED THERAPEUTIC BRACELET.
FI920701A0 (en) ANORDNING FOER THERAPEUTIC TRYCK- BEHANDLING.
ES1018837Y (en) PERFECTED THERAPEUTIC BRACELET.
ES1018236Y (en) IMPROVED THERAPEUTIC BRACELET.